Fatigue on tirzepatide and semaglutide-related fatigue can create a cycle where poor sleep worsens digestive symptoms, digestive discomfort disrupts sleep further, and the combined effect makes side effects harder to tolerate
However, no large-scale clinical trials have specifically evaluated this combined formulation, so any additional claims beyond formulation stability should be viewed cautiously
Similar to insulin resistance, some patients may develop resistance or diminished sensitivity to GLP-1 effects over time
Some researchers recommend against using alpha-lipoic acid for this purpose
Access and affordability are significant challenges, as are governmental policies, such as the current prohibition on Medicare coverage for weight loss medications in the US, restrict availability for many individuals who could benefit from these therapies